(Q39005887)
Statements
1 reference
Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle (English)
1 reference
Matthieu Blanchet
1 reference
Camille Sureau
1 reference
Patrick Labonté
1 reference
6 April 2014
1 reference
1 reference
106
1 reference
111-115
1 reference
Identifiers
1 reference
1 reference